Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

This Exploratory Clinical Trial Grants program (PAR-24-279) from the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases supports clinical trial research in arthritis, musculoskeletal, and skin diseases. The R61 mechanism requires clinical trials and represents a re-issue of PAR-24-035, updated to reflect the NIH's Simplifying Review of Research Project Grant Applications policy changes. The program aims to advance clinical research in these disease areas through exploratory clinical trials. This funding opportunity welcomes applications from a wide range of eligible organizations including higher education institutions, nonprofits, for-profit organizations, small businesses, tribal organizations, and government entities. The program uses the R61 grant mechanism specifically designated for clinical trial research.